NEWS & MEDIA

MEET US AT THE 7^TH ANNUAL ION CHANNEL RETREAT

Vancouver, June 29^th - July 1^st, 2009

We look forward to welcome you at the 7^th Annual Ion Channel Retreat June 29^th - July 1^st, 2009. Please come to see us at the booth of our North American distributor ReachBio. You will have the chance to exchange the latest developments in ion channel technology with our scientist Dr. Ralf Kettenhofen.

 

NANION AND AXIOGENESIS PRESENT PARALLEL PATCH CLAMP RECORDINGS OF ACTION POTENTIALS FROM Cor.At® CARDIOMYOCYTES

Munich, Germany, June 23^rd, 2009

Stem cell derived cardiomyocytes were analyzed using Nanion's automated patch clamp systems, the Patchliner and the Port-a-Patch to validate ion channel composition, the presence of action potentials and the effect of compounds on cardiac ion channels.

For the press release Click here!

 

Handelsblatt: CELLS FOR DRUG DEVELOPMENT

Düsseldorf, Germany June 9^th 2009

Pharmaceutical companies can test the effectiveness and cardiac toxicity of new drugs much earlier: Biotechnologists from Axiogenesis AG in Cologne cultivate human and mouse heart cells which can be used to test new active compounds. With their current capabilities the company can produce several billion cells per week. For the complete article Click here! (German)

 

CO-DEVELOPMENT AND MARKETING AGREEMENT WITH ROCHE

Roche and Axiogenesis AG have entered into a co-development and marketing agreement for the development and distribution for Axiogenesis' Cor.At® 100% pure cardiomyocytes platform as an integral part of the xCELLigence life cell analysis system.

For more information download press release Click here!